Métodos para descubrir uso promotor alternativo y la regulación transcripcional de murino BCRP1

7.8K visualizaciones

Citado por 1

11:02 min.

27 de mayo de 2016

10.3791/53827-v

27 de mayo de 2016

7.8K visualizaciones

Karthika Natarajan¹^,² , Yi Xie¹^,³ , Takeo Nakanishi⁴ , Rebecca S. Moreci⁵^,⁶ , Pancharatnam Jeyasuria⁷ , Arif Hussain¹^,³^,⁸^,⁹ , Douglas D. Ross¹^,³^,⁸^,⁹^,¹⁰^,¹¹

¹Greenebaum Cancer Center, University of Maryland School of Medicine, ²Pharmaceutical Sciences, University of Maryland School of Pharmacy, ³Baltimore VA Medical Center, ⁴Membrane Transport and Biopharmaceutics, School of Pharmaceutical Sciences, Kanazawa University, ⁵Obstetrics, Gynecology and Reproductive Science, University of Pittsburgh, ⁶Magee Women's Research Institute, ⁷Obstetrics, Gynecology, Perinatal Research Branch (NICHD), Wayne State University School of Medicine, ⁸Medicine, University of Maryland School of Medicine, ⁹Pathology, University of Maryland School of Medicine, ¹⁰Pharmacology, University of Maryland School of Medicine, ¹¹Experimental Therapeutics, University of Maryland School of Medicine

Con el murino transportador ABC BCRP1 (Abcg2) como un ejemplo, en-silico protocolos se presentan para detectar el uso de promotor alternativo en los genes expresados en tejidos de ratón, y para evaluar la funcionalidad de los promotores alternativos identificados mediante los ensayos de reportero.